Stamford, CT -- (SBWIRE) -- 01/18/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Cardica, Inc. (NASDAQ:CRDC), Oclaro, Inc. (NASDAQ:OCLR), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), Alimera Sciences Inc (NASDAQ:ALIM).
Cardica, Inc. (NASDAQ:CRDC) opened its last trade at the price of $1.14. Its closing price was $1.19 after gaining 5.31% for the day. The company traded with the total volume of 1.02 million shares, while its average trading volume remained 388,533.00 shares. The beta of this stock stands at 1.14. Cardica, Inc. designs, manufactures, and markets automated anastomotic systems for use by cardiac surgeons to perform coronary bypass surgery in the United States and internationally.
For How Long CRDC will Fight for Profitability? Read This Trend Analysis report
Oclaro, Inc. (NASDAQ:OCLR) percentage change surged 0.3% to close at $2.76 with the total traded volume of 1.01 million shares, along with average volume of 1.12 million shares. The 52 week range of the stock remained $0.88 - $2.87, while its day lowest price was $2.70. The share price hit the day highest price of $2.87. Oclaro, Inc. designs, manufactures, and markets lasers and optical components, modules, and subsystems for the optical communications, industrial, and consumer laser markets worldwide. The company’s products generate, detect, amplify, combine, and separate light signals in telecom networks.
For How Long OCLR’s Gloss will Attract Investors? Find out via this report
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) traded on volume of 1.01 million shares in the last session against average volume of 1.18 million shares. The company started its trading session with the price of $3.34 and closed at $3.40 by scoring 3.03%. Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, discovers and develops novel and small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders.
Will RIGL Continue To Move Higher? Find Out Here
Alimera Sciences Inc (NASDAQ:ALIM) started its last trading session with the price of $7.20 and closed at $7.88 by scoring 9.60%. The stock traded with total volume of 1.00 million shares, while the average trading volume remained 410,338.00 shares. The beta value of this stock stands at 1.59. Day range for the stock was $7.20 - $8.44. Alimera Sciences, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. The company focuses on diseases affecting the back of the eye or retina.
Why Should Investors Buy ALIM After The Recent Gain? Just Go Here and Find Out
About Wall Street Pennies
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)